KaNDy Therapeutics Announces Positive Phase 2b Data in Post-Menopausal Women with its Lead Non-Hormonal Product NT-814

KaNDy Therapeutics Announces Positive Phase 2b Data in Post-Menopausal Women with its Lead Non-Hormonal Product NT-814 ~ Phase 2b dose range finding study showed rapid and highly significant [...]

Contact Us

Please fill out the form to get in touch with us.

Not readable? Change text. captcha txt